Fascin is involved in the chemotherapeutic resistance of breast cancer cells predominantly via the PI3K/Akt pathway

BACKGROUND: A major therapeutic challenge for breast cancer is the ability of cancer cells to evade killing of conventional chemotherapeutic agents. We have recently reported the actin-bundling protein (fascin) as a major regulator of breast cancer metastasis and survival. METHODS: Survival of breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghebeh, H, Al-Khaldi, S, Olabi, S, Al-Dhfyan, A, Al-Mohanna, F, Barnawi, R, Tulbah, A, Al-Tweigeri, T, Ajarim, D, Al-Alwan, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200093/
https://www.ncbi.nlm.nih.gov/pubmed/25117814
http://dx.doi.org/10.1038/bjc.2014.453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200093/
https://www.ncbi.nlm.nih.gov/pubmed/25117814
http://dx.doi.org/10.1038/bjc.2014.453

Ejemplares similares